Smartstop Self Storage REIT (SMA) Stock Price, News & Analysis

Company Overview

Symmetry Medical Inc. (Symmetry) is a medical device solutions company, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry, and other medical device markets (including but not limited to arthroscopy, dental, laparoscopy, osteobiologic, and endoscopy segments). It also manufactures specialized non-healthcare products, primarily in the aerospace industry. The Company operates in two segments: original equipment manufacturer (OEM) solutions and symmetry surgical. On August 15, 2011, the Company acquired PSC Industries, Inc's Olsen Medical division. On December 29, 2011 it acquired the surgical instruments product portfolio from Codman & Shurtleff, Inc., a Johnson & Johnson Company.

Key Stats

• Today's Range: $33.55 to $34.93
• 50-Day Range: $13,350.00 to $16,000.00
• 52-Week Range: N/A
• Volume: 768,299 shs
• Average Volume: 473,016 shs
• Market Capitalization: $1.93 billion
• P/E Ratio: N/A
• Dividend Yield: 4.68%
• Price Target: $39.10
• Consensus Rating: Buy

SMA Stock Analysis - Frequently Asked Questions

How were Smartstop Self Storage REIT's earnings last quarter?

Smartstop Self Storage REIT Inc (NYSE:SMA) posted its earnings results on Wednesday, May, 7th. The healthcare company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. The healthcare company had revenue of $65.45 million for the quarter, compared to analysts' expectations of $63.63 million. Smartstop Self Storage REIT had a negative trailing twelve-month return on equity of 2.18% and a negative net margin of 3.68%.
Read the conference call transcript.

When did Smartstop Self Storage REIT IPO?

Smartstop Self Storage REIT (SMA) raised $810 million in an initial public offering on Wednesday, April 2nd 2025. The company issued 27,000,000 shares at $30.00 per share.

When does the company's lock-up period expire?

Smartstop Self Storage REIT's lock-up period expires on Monday, September 29th. Smartstop Self Storage REIT had issued 27,000,000 shares in its public offering on April 2nd. The total size of the offering was $810,000,000 based on an initial share price of $30.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Who are Smartstop Self Storage REIT's major shareholders?

Smartstop Self Storage REIT's top institutional investors include Aberdeen Group plc (0.83%), Allspring Global Investments Holdings LLC (0.66%), Chilton Capital Management LLC (0.39%) and Peregrine Capital Management LLC (0.27%). Insiders that own company stock include H Michael Schwartz, Michael O Terjung, Wayne Johnson and Nicholas Look.
View institutional ownership trends.

What other stocks do shareholders of Smartstop Self Storage REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Smartstop Self Storage REIT investors own include Consort Medical plc (CSRT.L) (CSRT), Achillion Pharmaceuticals (ACHN), Boeing (BA), Cencora (COR), Alphabet (GOOG), Illumina (ILMN) and Newcrest Mining (NCM).

Company Calendar

• Last Earnings: 5/07/2025
• Ex-Dividend for 7/15 Dividend: 6/30/2025
• Record date for 7/15 Dividend: 7/01/2025
• Dividend Payable: 7/15/2025
• Record date for 8/15 Dividend: 7/31/2025
• Ex-Dividend for 8/15 Dividend: 7/31/2025
• Today: 8/02/2025
• Next Earnings (Confirmed): 8/06/2025
• Dividend Payable: 8/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:SMA
• CIK: 1292055
• Web: www.smartstopselfstorage.com
• Phone: +1-574-2682252
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Smartstop Self Storage REIT: $39.10
• High Price Target: $44.00
• Low Price Target: $36.00
• Potential Upside/Downside: +12.4%
• Consensus Rating: Buy
• Rating Score (0-4): 3.25
• Research Coverage: 12 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.62 million
• Net Margins: -3.68%
• Pretax Margin: -3.24%
• Return on Equity: -2.18%
• Return on Assets: -0.46%

Debt

• Debt-to-Equity Ratio: 3.62
• Current Ratio: 3.23
• Quick Ratio: 3.23

Sales & Book Value

• Annual Sales: $237.01 million
• Price / Sales: 8.14
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 55,460,000
• Free Float: 52,407,000
• Market Cap: $1.93 billion
• Optionable: Not Optionable
• Beta: N/A